Dr. Takuma Hayashi

Business news, market intelligence, and global industry analysis.

The Latest

VA Tech Wabag (NSE: WABAG) wins order from CMWSSB for 45 MLD Chennai TTRO plant

Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway

Representative image of enterprise cloud cybersecurity infrastructure illustrating how Accenture plc and Google Cloud are strengthening cloud security defenses against AI-driven cyber threats and multi-cloud security risks.

How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure

Four-decade-first: Lok Sabha votes down no-confidence motion against Speaker Om Birla

Dr. Takuma Hayashi identifies LMP2 deficiency as key to uterine LMS, ushering in new era of precision cancer treatment

Dr. Takuma Hayashi’s molecular discovery of LMP2 deficiency in uterine LMS marks a breakthrough in precision oncology, unlocking new diagnostic and treatment pathways.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

June 22, 2025